US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist
  • 1.5800
  • -0.0500-3.07%
Close Dec 13 16:00 ET
  • 1.5999
  • +0.0199+1.26%
Post 18:59 ET
9.63MMarket Cap-0.61P/E (TTM)

Can-Fite BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-8.27%743K
-21.32%155K
-3.92%196K
-3.92%196K
-4.39%196K
-5.04%810K
-3.43%197K
-18.73%204K
-18.40%204K
38.51%205K
Operating revenue
-8.27%743K
-21.32%155K
-3.92%196K
-3.92%196K
-4.39%196K
-5.04%810K
-3.43%197K
-18.73%204K
-18.40%204K
38.51%205K
Cost of revenue
Gross profit
Operating expense
-18.05%8.94M
-39.36%1.99M
-25.78%2.06M
-12.93%1.98M
12.93%2.91M
-20.37%10.91M
-22.50%3.28M
-26.16%2.78M
-32.78%2.27M
11.04%2.58M
Selling and administrative expenses
-5.98%2.96M
-12.59%722K
2.83%762K
-24.09%624K
12.33%847K
-18.26%3.14M
-26.97%826K
-9.85%741K
-6.16%822K
-25.79%754K
-General and administrative expense
-5.98%2.96M
-12.59%722K
2.83%762K
-24.09%624K
12.33%847K
-18.26%3.14M
-26.97%826K
-9.85%741K
-6.16%822K
-25.79%754K
Research and development costs
-22.93%5.98M
-48.37%1.27M
-36.20%1.3M
-6.61%1.36M
13.18%2.06M
-21.19%7.76M
-20.86%2.45M
-30.72%2.04M
-42.08%1.45M
39.75%1.82M
Operating profit
18.83%-8.2M
40.51%-1.83M
27.52%-1.87M
13.82%-1.78M
-14.43%-2.71M
21.38%-10.1M
23.46%-3.08M
26.70%-2.57M
33.93%-2.07M
-9.17%-2.37M
Net non-operating interest income expense
138.83%492K
-67.44%113K
134.09%103K
194.21%114K
353.13%162K
3,333.33%206K
211.58%347K
-60.00%44K
-40.70%-121K
-121.84%-64K
Non-operating interest income
127.93%506K
----
----
----
----
825.00%222K
----
----
----
----
Total other finance cost
-12.50%14K
414.40%393K
-134.09%-103K
-194.21%-114K
-353.13%-162K
-11.11%16K
-137.31%-125K
60.00%-44K
40.70%121K
121.84%64K
Other net income (expense)
124.38%69K
-228.05%-283K
Gain on sale of security
124.38%69K
----
----
----
----
-228.05%-283K
----
----
----
----
Income before tax
24.96%-7.63M
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
19.36%-10.17M
26.69%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
Income tax
0
0
Net income
24.96%-7.63M
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
19.36%-10.17M
26.69%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
Net income continuous Operations
24.96%-7.63M
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
19.36%-10.17M
26.69%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
Minority interest income
Net income attributable to the parent company
24.96%-7.63M
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
19.36%-10.17M
26.69%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
Preferred stock dividends
Other preferred stock dividends
0
0
Net income attributable to common stockholders
24.96%-7.63M
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
33.09%-10.17M
54.99%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
Basic earnings per share
0.00%-3
-1.5166
66.88%-0.4302
49.83%-0.4042
27.51%-0.6489
66.67%-3
0
56.70%-1.2991
56.11%-0.8058
23.11%-0.8951
Diluted earnings per share
0.00%-3
-1.5166
66.88%-0.4302
49.83%-0.4042
27.51%-0.6489
66.67%-3
0
56.70%-1.2991
56.11%-0.8058
23.11%-0.8951
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -8.27%743K-21.32%155K-3.92%196K-3.92%196K-4.39%196K-5.04%810K-3.43%197K-18.73%204K-18.40%204K38.51%205K
Operating revenue -8.27%743K-21.32%155K-3.92%196K-3.92%196K-4.39%196K-5.04%810K-3.43%197K-18.73%204K-18.40%204K38.51%205K
Cost of revenue
Gross profit
Operating expense -18.05%8.94M-39.36%1.99M-25.78%2.06M-12.93%1.98M12.93%2.91M-20.37%10.91M-22.50%3.28M-26.16%2.78M-32.78%2.27M11.04%2.58M
Selling and administrative expenses -5.98%2.96M-12.59%722K2.83%762K-24.09%624K12.33%847K-18.26%3.14M-26.97%826K-9.85%741K-6.16%822K-25.79%754K
-General and administrative expense -5.98%2.96M-12.59%722K2.83%762K-24.09%624K12.33%847K-18.26%3.14M-26.97%826K-9.85%741K-6.16%822K-25.79%754K
Research and development costs -22.93%5.98M-48.37%1.27M-36.20%1.3M-6.61%1.36M13.18%2.06M-21.19%7.76M-20.86%2.45M-30.72%2.04M-42.08%1.45M39.75%1.82M
Operating profit 18.83%-8.2M40.51%-1.83M27.52%-1.87M13.82%-1.78M-14.43%-2.71M21.38%-10.1M23.46%-3.08M26.70%-2.57M33.93%-2.07M-9.17%-2.37M
Net non-operating interest income expense 138.83%492K-67.44%113K134.09%103K194.21%114K353.13%162K3,333.33%206K211.58%347K-60.00%44K-40.70%-121K-121.84%-64K
Non-operating interest income 127.93%506K----------------825.00%222K----------------
Total other finance cost -12.50%14K414.40%393K-134.09%-103K-194.21%-114K-353.13%-162K-11.11%16K-137.31%-125K60.00%-44K40.70%121K121.84%64K
Other net income (expense) 124.38%69K-228.05%-283K
Gain on sale of security 124.38%69K-----------------228.05%-283K----------------
Income before tax 24.96%-7.63M45.28%-1.65M30.33%-1.76M23.78%-1.67M-4.77%-2.55M19.36%-10.17M26.69%-3.02M25.62%-2.53M31.94%-2.19M-29.61%-2.43M
Income tax 00
Net income 24.96%-7.63M45.28%-1.65M30.33%-1.76M23.78%-1.67M-4.77%-2.55M19.36%-10.17M26.69%-3.02M25.62%-2.53M31.94%-2.19M-29.61%-2.43M
Net income continuous Operations 24.96%-7.63M45.28%-1.65M30.33%-1.76M23.78%-1.67M-4.77%-2.55M19.36%-10.17M26.69%-3.02M25.62%-2.53M31.94%-2.19M-29.61%-2.43M
Minority interest income
Net income attributable to the parent company 24.96%-7.63M45.28%-1.65M30.33%-1.76M23.78%-1.67M-4.77%-2.55M19.36%-10.17M26.69%-3.02M25.62%-2.53M31.94%-2.19M-29.61%-2.43M
Preferred stock dividends
Other preferred stock dividends 00
Net income attributable to common stockholders 24.96%-7.63M45.28%-1.65M30.33%-1.76M23.78%-1.67M-4.77%-2.55M33.09%-10.17M54.99%-3.02M25.62%-2.53M31.94%-2.19M-29.61%-2.43M
Basic earnings per share 0.00%-3-1.516666.88%-0.430249.83%-0.404227.51%-0.648966.67%-3056.70%-1.299156.11%-0.805823.11%-0.8951
Diluted earnings per share 0.00%-3-1.516666.88%-0.430249.83%-0.404227.51%-0.648966.67%-3056.70%-1.299156.11%-0.805823.11%-0.8951
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Heat List
US
Overall
Symbol
Price
% Chg

No Data